Pyxis Oncology is trading 9.05% up at $3.09 after rebounding from the August 11, 2026 close, without a new company-specific announcement clearly explaining the August 12 move.
- Shares fell 26.11% on August 11 to close at $2.83.
- Investors may be positioning ahead of the expected August 13 earnings release, but that remains unconfirmed.
- Broader markets are only modestly higher, limiting confidence in a macro explanation.